1
2
3
4
5
6
7
8
9
10
11
12
13 | Licensing Program Analyst (LPA) Kimberly Lyman met with Program Manager Dan Robinson and Director of Quality Compliance Garry Larabee in the Orange County Regional Office to deliver an amended report for the above allegation.
During the course of the investigation, LPA toured the facility, interviewed staff and witnesses as well as reviewed and obtained pertinent documentation such as medication orders and client intake information. Regarding the allegation that staff did not follow doctor's medication order, the investigation revealed the folloiwng: Facility medication protocol is for physician to review and approve all psychotropic medications upon admittance into the facility. C1 acknowledged this process on the medication consent form. If facility physician does not approve the psychotropic drug perviously prescribed, Client is not able to have the medication while in the program. LPA reviewed approved medications and they matched approved drug list from facility physician. However, witness interviewed during the investigation indicated C1 admitted with a prescribed medication not on the medication list. Due to conflicting information, LPA is unable to corroborate the allegation. Therefore, the allegation is deemed unsubstantiated, meaning that although the allegation may have happened or are valid, there is not a preponderance of the evidence to prove that the alleged violation occurred. Exit interview conducted and a copy of this report was provided.. |